EMD-19183
Beta-galactosidase (LacZ) in complex with synthetic glycosyrin.
EMD-19183
Single-particle1.42 Å
Deposition: 18/12/2023Map released: 01/01/2025
Last modified: 01/04/2026
Sample Organism:
Escherichia coli
Sample: beta-galactosidase
Fitted models: 8ri8
Deposition Authors: Hardenbrook NJ, Sheng Y
,
Zhang P
Sample: beta-galactosidase
Fitted models: 8ri8
Deposition Authors: Hardenbrook NJ, Sheng Y
,
Zhang P
Bacterial pathogen deploys the iminosugar glycosyrin to manipulate plant glycobiology.
Sanguankiattichai N
,
Chandrasekar B,
Sheng Y
,
Hardenbrook N
,
Tabak WWA
,
Drapal M
,
Kaschani F
,
Grunwald-Gruber C
,
Krahn D
,
Buscaill P
,
Yamamoto S,
Kato A
,
Nash R
,
Fleet G,
Strasser R
,
Fraser PD,
Kaiser M
,
Zhang P
,
Preston GM
,
van der Hoorn RAL
(2025) Science , 388 , 297 - 303
,
Chandrasekar B,
Sheng Y
,
Hardenbrook N
,
Tabak WWA
,
Drapal M
,
Kaschani F
,
Grunwald-Gruber C
,
Krahn D
,
Buscaill P
,
Yamamoto S,
Kato A
,
Nash R
,
Fleet G,
Strasser R
,
Fraser PD,
Kaiser M
,
Zhang P
,
Preston GM
,
van der Hoorn RAL
(2025) Science , 388 , 297 - 303
Grant Support:
- Biotechnology and Biological Sciences Research Council (BBSRC): BB/T015128/1 (United Kingdom)
- Biotechnology and Biological Sciences Research Council (BBSRC): BB/R017913/1 (United Kingdom)
- European Research Council (ERC): 101021133 (European Union)
- National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID): U54 AI170791-7522 (United States)
- Wellcome Trust: 206422/Z/17/Z (United Kingdom)
